α2-macroglobulin attenuates β-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons

Journal of Neurochemistry

Volumn 70, Issue 3, 1998, Pages 1182-1188

  Du, Yansheng ^a   Bales, Kelly R ^a   Dodel, Richard C ^a,b   Liu, Xiaodong ^a   Glinn, Michele A ^a   Horn, Jeffrey W ^a   Little, Sheila P ^a   Paul, Steven M ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Alzheimer's disease; Neurotoxicity; 2 Macroglobulin; Amyloid peptides

Indexed keywords

ALPHA 2 MACROGLOBULIN; AMYLOID BETA PROTEIN; CHYMOTRYPSIN INHIBITOR; ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID BETA PROTEIN[1-40]; NEUROTOXIN; PEPTIDE FRAGMENT; PROTEINASE; SERINE PROTEINASE INHIBITOR;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CYTOTOXICITY; FETUS; NERVE CELL CULTURE; NEURITIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENDOCYTOSIS; ENZYMOLOGY; METABOLISM; NERVE CELL; SPRAGUE DAWLEY RAT;

ANIMALIA;

ALPHA 1-ANTICHYMOTRYPSIN; ALPHA-MACROGLOBULINS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; ENDOCYTOSIS; ENDOPEPTIDASES; NEURONS; NEUROTOXINS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; SERINE PROTEINASE INHIBITORS;

EID: 0031594756     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70031182.x     Document Type: Article

References (41)

1. Barrow C. J., Yasuda A., Kenny P. T. M., and Zagorski M. G. (1992) Solution conformation and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease. J. Mol. Biol. 225, 1075-1093.
2. 2-macroglobulin indicate an acute phase state in Alzheimer's disease cortices. FEBS Lett. 285, 111-114.
3. Boggs L. N., Fuson K. S., Baez M., Churgay L., McClure D., Becker G., and May P. C. (1996) Clusterin (Apo J) protects against in vitro amyloid-β(1-40) neurotoxicity. J. Neurochem. 67, 1324-1327.
4. 2-Macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J. 6, 3345-3353.
5. Busciglio J., Lorenzo A., and Yankner B. A. (1992) Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol. Aging 13, 609-612.
6. Businaro R., Fabrizi C., Fumagalli L., and Lauro G. M. (1992) Synthesis and secretion of alpha-2-macroglobulin by human glioma established cell lines. Exp. Brain Res. 88, 213-218.
7. Drian M.-J., Kamenka J.-M., Pirat J.-L., and Privat A. (1991) Non-competitive antagonists of N-methyl-D-aspartate prevent spontaneous neuronal death in primary cultures of embryonic rat cortex. J. Neurosci. Res. 29, 133-138.
8. 2-Macroglobulin as a β-amyloid peptide-binding plasma protein. J. Neurochem. 69, 299-305.
9. Dziegielewska K. M., Saunders N. R., Schejter E. J., Zakut H., Zevin-Sonkin D., Zisling R., and Soreq H. (1986) Synthesis of plasma proteins in fetal, adult, and neoplastic human brain tissue. Exp. Biol. 115, 93-104.
10. Eriksson S., Janciauskiene S., and Lannfelt L. (1995) Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation. Proc. Natl. Acad. Sci. USA 92, 2313-2317.
11. Fraser P. E., Nguyen J. T., Chin D. T., and Kirschner D. A. (1992) Effects of sulfate ions on Alzheimer β/A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions. J. Neurochem. 59, 1531-1540.
12. Ganter U., Strauss S., Jonas U., Weidemann A., Beyreuther K., Volk B., Berger M., and Bauer J. (1991) Alpha-2-macroglobulin synthesis in interleukin 6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells. Potential significance for the processing of Alzheimer beta-amyloid precursor protein. FEBS Lett. 282, 127-131.
13. 2-Macroglobulin synthesis in an astrocyte subpopulation. J. Neurochem. 49, 1139-1145.
14. Higuchi M., Ito T., Imai Y., Iwaki T., Hattori M., Kohsaka S., Niho Y., and Sakaki Y. (1994) Expression of the alpha-2-macroglobulin-encoding gene in rat brain and cultured astrocytes. Gene 142, 155-162.
15. Ishii M., Osada T., Gliemann J., and Ikai A. (1996) Neurite-promoting effect of alpha 2-macroglobulin in rat cerebral cortex is mainly associated with alpha 2-macroglobulin receptor. Brain Res. 737, 269-274.
16. Janciauskiene S., Garcia de Frutos P., Carlemalm E., Dahlback B., and Eriksson S. (1995) Inhibition of Alzheimer beta-peptide fibril formation by serum amyloid P component. J. Biol. Chem. 270, 26041-26044.
17. Kirschner D. J., Inoye H., Duffy L. K., Sinclair A., Lind M., and Selkoe D. J. (1987) Synthetic peptides homologous to β protein from Alzheimer disease form amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. USA 84, 6953-6987.
18. Knauer M. F., Sorechan B., Burdick D., Kosmoski J., and Glabe C. G. (1992) Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/β protein. Proc. Natl. Acad. Sci. USA 89, 7437-7441.
19. Kodelja V., Heisig M., Northemann W., Heinrich P. C., and Zimmermann W. (1986) Alpha-2-macroglobulin gene expression during rat development studied by in situ hybridization. EMBO J. 5, 3151-3156.
20. Lopes M. B., Bogaev C. A., Gonias S. L., and Vandenberg S. R. (1993) Expression of alpha-2-macroglobulin receptor/low density lipoprotein receptor-related protein is increased in reactive and neoplastic glial cells. FEBS Lett. 338, 301-305.
21. Ma J., Yee A., Brewer H. B. Jr., Das S., and Potter H. (1994) Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 372, 92-94.
22. Ma J., Brewer B. H. Jr., and Potter H. (1996) Alzheimer Aβ neurotoxicity: promotion by antichymotrypsin, ApoE4; inhibition by Aβ-related peptides. Neurobiol. Aging 17, 773-780.
23. Mattson M. P., Tomaselli K. J., and Rydel R. E. (1993a) Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621, 35-49.
24. Mattson M. P., Barger S. W., Cheng B., Lieberburg I., Smith-Swintosky V. L., and Rydel R. E. (1993b) β-Amyloid precursor protein metabolites and loss of neuronal calcium homeostasis in Alzheimer's disease. Trends Neurosci. 16, 409-415.
25. Mori T., Iijima N., Kitabatake K., and Kohsaka S. (1990) Alpha 2-macroglobulin is an astroglia-derived neurite-promoting factor for cultured neurons from rat central nervous system. Brain Res. 527, 55-61.
26. Naiki H., Higuchi K., Hosokawa M., and Takeda T. (1989) Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T. Anal. Biochem. 177, 244-249.
27. Pike C. J., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1991) In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563, 311-314.
28. Rebeck G. W., Reiter J. S., Strickland D. K., and Hyman B. T. (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11, 575-580.
29. Roses A. D. (1994) Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on ApoE genotype and duration of disease. J. Neuropathol. Exp. Neurol. 53, 429-437.
30. Saitoh S., Lijima N., Ikeda M., Nakajima K., Kimura M., Katsuki M., Mori T., and Kohsaka S. (1992) De novo production of alpha-2-macroglobulin in cultured astroglia from rat brain. Brain Res. Mol. Brain Res. 12, 155-161.
31. Selkoe D. J. (1994) Alzheimer's disease: a central role for amyloid. J. Neuropathol. Exp. Neurol. 53, 438-447.
32. Simmons L. K., May P. C., Tomaselli K. J., Rydel R. E., Fuson K. S., Brigham E. F., Wright S., Lieberburg I., Becker G. W., Brems D. N., and Li W. (1994) Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45, 373-379.
33. Strauss S., Bauer J., Ganter U., Jona S., Berger M., and Volk B. (1992) Detection of interleukin-6 and α2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab. Invest. 66, 223-230.
34. Tooyama I., Kawamata T., Akiyama H., Moestrup S. K., Gliemann J., and McGeer P. (1993) Immunohistochemical study of alpha 2 macroglobulin receptor in Alzheimer and control postmortem human brain. Mol. Chem. Neuropathol. 18, 153-160.
35. van Gool D., De Strooper B., van Leuven F., Triau E., and Dom R. (1993) α2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease. Neurobiol. Aging 14, 233-237.
36. Webster S., Bradt B., Rogers J., and Cooper N. (1997) Aggregation state-dependent activation of the classical complement pathway by the amyloid β peptide. J. Neurochem. 69, 388-398.
37. Wisniewski T., Castano E., Ghiso J., and Frangione B. (1993) Cerebrospinal fluid inhibits Alzheimer beta-amyloid fibril formation in vitro. Ann. Neurol. 34, 631-633.
38. Wisniewski T., Castano E., Golabek A., Vogel T., and Frangione B. (1994) Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145, 1030-1035.
39. Yang D.-S., Smith J. D., Zhou Z., Gandy S. E., and Martins R. N. (1997) Characterization ot the binding of amyloid-β peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma. J. Neurochem. 68, 721-725.
40. Yankner B. A., Duffy L. K., and Kirschner D. A. (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250, 279-282.
41. 1-antichymotrypsin. Amyloid: Int. J. Exp. Clin. Invest. 3, 156-161.